Beneficial effect of Gremin, a proprietary dual antioxidant formulation on skeletal muscle injury - in-vivo

Shankaranarayanan Jeyakodi*, Arunkanth Krishnakumar, Dinesh Kumar Chellappan, Rajesh Subbanna, Sachin Bansal

Published Date: 2021-09-30
DOI10.36648/ipctn.21.06.34

Shankaranarayanan Jeyakodi1*, Arunkanth Krishnakumar1, Dinesh Kumar Chellappan2, Rajesh Subbanna3, Sachin Bansal3

1ZeusHygia Life Sciences Pvt. Ltd., Hyderabad, India

2Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia

3Palamur Biosciences Pvt. Ltd., Telangana, India

*Corresponding Author:
Shankaranarayanan Jeyakodi
ZeusHygia Life Sciences Pvt. Ltd.
Hyderabad, India
E-mail: shankar@zeushygia.com

Received Date: September 04, 2021; Accepted Date: September 27, 2021; Published Date: September 30, 2021

Citation: Jeyakodi S, Krishnakumar A, Chellappan DK, Subbanna R, Bansal S (2021) Beneficial Effect of Gremin, a Proprietary Dual Antioxidant Formulation on Skeletal Muscle Injury - In vivo. J Nutraceuticals Food Sci Vol.6 No.8:34

Visit for more related articles at Journal of Nutraceuticals and Food Science

Abstract

Background: Tissue repair capabilities in mammals are relatively limited, and there is a growing interest to discover newer therapeutic interventions for the muscle regeneration process. While Curcumin and Green Coffee extract has previously shown to have beneficial effect individually, there is no study to examine the synergistic effects of these compounds. We, therefore, attempted to study the effect of Gremin, a proprietary encapsulated ingredient formulation in a mouse model with BaCl2 induced muscle injury.

Methods and Findings: Adult male Swiss Albino mice were divided into four groups (n=6 per group) as vehicle control, BaCl2 control, Gremin and reference compound group. Animals were administered with BaCl2 injection to induce muscle injury, except for vehicle control. Gremin and the reference compound was administered at a dose level of 200 mg/kg/b.w daily, for up to 17 days via the oral route. Biochemical markers viz., TNF-α, Creatine Kinase (CK), Lactate Dehydrogenase (LDH), and histopathology for necrosis, were assessed.

Results: Histopathology analysis of the mouse muscle tissues demonstrated significant protective effects of Gremin on muscle injury. Gremin group exhibited reduced levels of LDH and CK enzyme biomarkers indicating muscle recovery.

Conclusion: Gremin Supplementation has beneficial effects on muscle injury and could be of immense value during post-injury rehabilitation.

Keywords

Gremin; Muscle injury; Biochemical markers; Histopathology

Introduction

Muscle repair and regeneration is closely linked processes that relies on the precise and timely sequencing of the proinflammatory and anti-inflammatory signals that occur postmuscle injury [1,2]. Following injury, resident stem (satellite) cells (SCs), re-enter the cell cycle and generate myoblasts that will participate in myofiber reconstitution or repair [3]. There are two types of skeletal muscle injury, one caused by direct destruction of muscle tissue and the other one by a contractile overload [4]. The healing phases for an injured muscle include inflammation, degeneration, regeneration and remodelling, which are considered to be common among the injury types, even though the initiating mechanism of damage most probably differs depending on the type of injury [5-7]. There is also considerable crosstalk between fibro-adipogenic, endothelial, and myogenic cells to coordinate connective tissue formation, angiogenesis, remodelling and myogenesis for the efficient reconstitution of functional muscle [8,9]. Studies have reported that the tissue repair capabilities in mammals are relatively limited, and hence there is a growing interest to discover newer therapeutic interventions for the skeletal muscle regeneration process [10]. Presently, the available treatment options for muscle injuries are limited and lead to significant muscle wasting as well as delay in muscle recovery.

Recent evidence suggests that various herbal extracts including green coffee bean extract from Coffee Robusta and curcumin from Curcuma longa have potent health benefits [11-13]. Green coffee Robusta beans contain a high amount of Chlorogenic Acids (CGA) which have been reported for their potent antioxidant, anti-diabetic, anti-obesity, anti-inflammatory and antimicrobial properties [13-17]. However, most of the CGA content is lost when coffee beans are heated at very high temperatures during the process of making coffee. Another interesting herbal molecule, curcumin, a natural dietary polyphenol, has been shown to have beneficial effects on skeletal muscle injury and also possesses numerous pharmacological properties, including antiinflammatory, immunomodulatory, antioxidant, and antiarthritic effects [18-21]. Oral supplementation of curcumin suppresses oxidative stress by decreasing the hydrogen peroxide levels in mouse skeletal muscles after downhill running [22]. Additionally, curcumin supplementation reduces serum CK activity, a marker for skeletal muscle damage [23]. Thus, curcumin has been established to have beneficial effects on skeletal muscle injury. As there is a growing interest in exploring the potential benefits of natural products as therapeutics for muscle injury, a combination of curcumin and green Coffee Robusta may therefore be a good treatment option.

We developed a proprietary ingredient formulation called Gremin, a combination of green coffee extract from Coffee Robusta and curcumin from Curcuma longa to treat muscle injury. We used a barium chloride (BaCl2) induced muscle injury model, which has been largely considered as a locally specific method for the study of muscle regeneration [24]. The main advantages of chemical injury with BaCl2 include both ease of use and its ability to reproducibly damage myofibers while preserving their associated satellite cells [25-26]. While curcumin and Green Coffee have been shown to have beneficial effects individually, there are no studies yet to examine the synergistic effects of these compounds at an optimized ratio. We, therefore, attempted to study the effect of Gremin, in a mouse model of BaCl2-induced muscle injury.

Methods

Animal experiments

Adult male Swiss Albino mice (aged 6 weeks-8 weeks) were conveniently housed in polypropylene cages in an animal room maintained with a 12-hrs light/dark cycle at 22â?? ± 2â?? and 55% ± 5% humidity. Animals were allowed free access to water and pelleted rodent feed. The feed and water were routinely analyzed and were considered not to contain any contaminants that we expect could reasonably affect the purpose or integrity of the study. The animals used in the present study were maintained according to the principles and guidelines of the Committee for Control and Supervision of Experiments on Animals (CPCSEA). All the protocols and procedures were approved by the Institutional Animal Ethics Committee (IAEC) (Project approval number: PAL/ IAEC/2020/5/01/05).

Animals were grouped based on stratified randomization by using body weights (G1-G4). Randomization was performed one day before the initiation of treatment. Additional animals were taken for randomization procedure. Animals at randomization were ensured to be within ± 20% of the mean body weight for each group. The study groups, detailed study plan and treatment schedule are presented in Table 1.

Grouping & Dose Group Dose (mg/kg b.w) Dose frequency Barium Chloride (BaCl2)-induction No of animals/ group
G1 (Vehicle control) 0.0 Daily for 17 Days (Distilled Water) - 6
G2 (Bacl2 control) 0.0 Daily for 17 Days (Distilled Water) Induction of muscle injury on 7th day 6
G3 (Gremin treatment) 200 Daily for 17 Days (Gremin) Induction of muscle injury on 7th day 6
G4 (Reference compound treatment) 200 Daily for 17 Days (Reference) Induction of muscle injury on 7th day 6

Table 1: Experimental study plan and treatment period.

Induction of muscle injury

To induce the muscle injury, 50 μL of a 1.2% (w/v) BaCl2 solution dissolved in Phosphate Buffered Saline (PBS) was injected to the right Tibialis Anterior (TA) muscles of the anaesthetized mice. Left TA muscle served as a contralateral control. The BaCl2 injection was administered to all animals on Day 7 of the treatment.

Test and reference compound treatment phase

The test agent, Gremin, was formulated using a platform technology where in Chlorogenic acid (Green coffee bean extract) was infused with Curcuminoids (Curcuma longa extract) under optimal processing conditions. The reference compound was a physical blend of green coffee bean extract and curcumin extract. Both test and reference agents were given once daily for 17 days by oral administration. Dose formulations of test compound Gremin was administered to the G3 group and the reference compound was administered to G4 at a dose level of 200 mg/ kg/b.w daily, up to 17 days by oral route and the dose-volume was maintained at 10 mL/kg bodyweight for 17 days. Group G2 was only administered with barium chloride (BaCl2). The vehicle, distilled water was administered to the vehicle control (G1) group at an equivolume of 10 mL/kg body weight, for up to 17 days.

The animals were observed for clinical signs (daily cage side observation); body weights and feed consumption; during the entire treatment period. All animals were observed for general clinical signs, morbidity/viability, twice daily throughout the observation period. Body weights of the animals were recorded on the day of receipt, on the day of randomization, on the day of dosing (day 1) and thereafter on days 4, 7, 10, 13, 16 for all groups. Blood samples for clinical biochemistry were collected from all animals from groups G1, G2 G3 and G4 on day 18. Blood samples were drawn from the retro-orbital plexus using a nonheparinized glass capillary tube. After centrifugation, the serum was separated in the pre-labelled vials and stored at -80â?? for further analysis.

Histopathological studies

Animals were sacrificed humanely by cervical dislocation on day 18 of the study after blood collection. Right, and Left TA muscle samples were collected and fixed with 10% buffered neutral formalin solution. Post-fixation, tissue samples were paraffin-embedded, 5-micron sections prepared and stained with Hematoxylin and Eosin (H&E).

Quantitative analysis of TNF-alpha, CK and LDH

TNF Alpha was measured by quantitative sandwich Enzyme- Linked Immunosorbent Assay (ELISA) (Krishgen Bio, USA) according to the manufacturer’s instructions. The values are expressed in pg/mL. CK and LDH were measured by a Beckman Coulter AU analyzer and the values were expressed as U/L. The intra- and inter-assay coefficients of variation were <5% and <10% respectively.

Statistical analysis

Differences were evaluated by one-way Analysis of Variance (ANOVA) using GraphPad Prism software, Version 5 (GraphPad Software Inc., CA, USA) and a p-value<0.05 was considered as statistically significant.

Results

The test and reference compounds were orally administered for 7 days after which BaCl2 injection was injected into the right tibialis anterior muscle of the animals to induce muscle injury. Treatment with the test compound, Gremin and the reference compound were continued for another 10 days after which the animals were euthanized, and tissue samples were collected and processed for further analysis. We assessed whether BaCl2 and Gremin treatment affected the body weight and found that these treatments did not induce any difference in body weights between the groups (Supplementary Data). Further 50 μl injection of 1.2% BaCl2 onto the right tibialis anterior muscle did not result in any mortality (Data not shown).

Further, to assess the effects of the test compound on BaCl2 induced injury, we carried out a histopathological analysis on H&E-stained tissue sections. We found typical necrotic lesions in the BaCl2 treated groups and found no such necrotic changes either in Gremin or reference compound treated animals (Figure 1).

nutraceuticals-tibialis

Figure 1: Representative H & E staining images of the tibialis anterior tissue sections of the leg; A): BaCl2 induced necrosis; B): Protection of BaCl2 induced muscle injury by Gremin.

Localized muscle injury could result in inflammation which has been shown to increase TNF-alpha levels [27]. To assess whether the test compound has an effect in reducing inflammation, we measured the TNF-alpha levels in the serum after 10 days of BaCl2 induced muscle injury. BaCl2 treatment did not increase TNFalpha levels in all study groups (Figure 2). TNF-alpha levels were comparable to that of the vehicle in the Gremin and reference treated mice.

nutraceuticals-endpoint

Figure 2: Measurement of TNF-alpha levels at the study endpoint, Data represents Mean ± SEM, n=6 in each group.

Creatine kinase, a well-established marker of muscle injury was assessed in the blood samples of mice from the control and treatment groups [28]. It was found that BaCl2 injection resulted in creatine kinase level-increase by 2.9-folds (p<0.01) in comparison to vehicle. Treatment of mice with the test compound, Gremin showed a significant 3-fold reduction when compared with the BaCl2-Control group (p<0.01). However, there was only a moderate 1.6-fold reduction in creatine kinase levels in the reference group (p<0.01) (Figure 3).

nutraceuticals-kinase

Figure 3: Measurement of creatin kinase enzyme activity at the study end point. Data are expressed as Mean ± SEM. ** p value<0.01 when compared with vehicle group. ## p value<0.01 when compared with BaCl2 control group.

Similarly, BaCl2 injection resulted in increased levels of LDH by 1.8-fold (p value <0.01) when compared to vehicle control animals. Treatment of Gremin reduced the LDH levels by 1.5-fold (P<0.01) when compared to BaCl2-control treatment while the effect of the reference compound was similar to that of the test compound resulting in a reduction of LDH levels by a factor of 1.4-fold (p value<0.01) (Figure 4).

nutraceuticals-dehydrogenase

Figure 4: Measurement of lactate dehydrogenase enzyme activity at the study endpoint. Data are expressed as Mean ± SEM. **p value<0.01 when compared with the vehicle group. ## p value<0.01 when compared with BaCl2 control group.

Discussion

Skeletal muscle injury and repair are ongoing processes. This homeostatic equilibrium is altered due to defective tissue regeneration capacity in many pathological states involving various organs such as the heart, lung, and tendons [29-31]. Tissue regeneration involves multiple pathways including antioxidant generation, inflammation, and recruitment of stem cells [32]. Ageing is associated with skeletal muscle loss or muscle wasting that could potentially involve one or multiple pathways. Skeletal muscle alterations are known to occur in several disease states such as COPD [30], and peripheral arterial disease [33]. Mostly, tissue injury occurs because of contractile overload occurring during physical workouts and sports. Drugs that can aid in tissue regeneration will be of immense addition to the existing treatment arsenal of anti-inflammatory drugs.

Curcuma longa and Coffee extract have been shown earlier to have enormous impact as natural antioxidants. In this report, we have demonstrated that a novel therapeutic “Gremin”, a proprietary infusion of Curcumin and Chlorogenic acid (Green Coffee Robusta) is better in the resolution of skeletal muscle injury as compared to the simple physical mixture of curcumin extract and green coffee bean extract. We induced skeletal muscle injury by standard BaCl2 model. The necrosis of the skeletal muscle induced by BaCl2 was completely resolved when the mice were treated with Gremin. Further, enzymes that were released during muscle injury such as, LDH and creatine kinase were significantly lowered in Gremin treated animals compared to the reference compound animals, which is indicative of the greater performance of this formulation in resolving skeletal muscle injury.

Curcumin has been shown to increase antioxidant activity by elevating Superoxide Dismutase (SOD), glutathione peroxidase and catalase in a parallel decrease of pro-oxidant molecules such as malondialdehyde, inflammatory molecules-IL-6 and TNFalpha [34]. In our study, BaCl2 injury did not induce inflammation as observed TNF-alpha levels were similar to the vehicle group. Consequently, there was no effect on TNF-alpha levels by Gremin as well as the reference compound. Previous studies have shown that curcumin ameliorates myocardial infarction in a model induced by β-adrenoreceptor antagonists isoproterenol hydrochloride (ISO) [35]. Similar to our study, curcumin treatment decreased the levels of skeletal muscle markers namely LDH and creatine kinase induced by ISO insult on myocardial tissue. The green coffee extract has several beneficial effects and has been shown to reduce inflammation evidenced by a decrease in CRP levels [36]. Chlorogenic acids (CGA), a key ingredient of coffee extract has been earlier demonstrated for bioavailability and CGA has been shown to down regulate several inflammatory genes [37]. The cytoprotective effects observed in this study is perhaps due to the synergistic effects of both curcumin and green tea extract.

One of the limitations of curcumin treatment is the limited bioavailability of oral administration. Pharmacokinetic studies on curcumin have revealed the oral bioavailability of curcumin was 0.06 μg/ml [38]. This level of curcumin is inadequate to achieve desirable effects in vivo. Hence, numerous attempts are being made to obtain a formulation that increases the oral bioavailability of curcumin [39,40]. Our formulation has shown significant biological activity on oral administration in a mouse model of muscle injury. Further, the platform technology-driven infusion process of curcumin with green coffee bean possibly plays a synergistic role in the efficient resolution of muscle injury. These effects could be replicated for various other diseases in which Gremin has shown positive biological effects including cancer, heart disease and inflammation. Another possible limitation of this study is the lack of data on pharmacokinetics and pharmacodynamics. However, the demonstration of biological activity of this novel Gremin formulation assures a positive development in this area of natural medicine.

Conclusion

Currently, there are limited treatment options for muscle injury aside from symptomatic treatment. In this study, we have demonstrated that a supplement of Gremin is highly beneficial for muscle injury treatment and could be of immense value for post-injury rehabilitation.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Credit Authorship Contribution Statement

Shankaranarayanan Jeyakodi: Conceptualization, Methodology, Data curation, Writing (original draft, review & editing). Arunkanth Krishnakumar: Data Curation, Validation. Dinesh Kumar Chellappan: Data Curation, Validation, Writing (Original Draft). Rajesh Subbanna: Data Curation, Validation, Writing (Original Draft). Sachin Bansal: Conceptualization, Methodology, Data curation, Writing (original draft, review & editing).

Declaration of Competing Interest

The authors report no declarations of interest.

References

open access journals, open access scientific research publisher, open access publisher
Select your language of interest to view the total content in your interested language

Viewing options

Flyer image

Share This Article